Clinical Trial Update: Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of nitrocamptothecin in patients with locally advanced or metastatic gastric or esophageal cancer; sponsor is Astex Pharmaceutical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: UNKNOWN